Combination Transfer of αCD19-TCRz-41BB and αCD22-TCRz-41BB CAR-T Cells for B-cell Hematologic Malignancy

NCT02903810 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Hematopoietic/Lymphoid Cancer

Interventions

BIOLOGICAL: Mixed CAR-T Transfer

Sponsor

Xuzhou Medical University